0455.HK HKSE
Tianda Pharmaceuticals Limited
1W: -8.5%
1M: +6.3%
3M: +38.8%
YTD: +14.6%
1Y: -34.1%
3Y: -50.3%
5Y: -41.9%
HK$0.12 ($0.02)
-0.00 (-1.67%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$748M
-2.2% ▼
5Y CAGR: -8.0%
Total Liabilities
$291M
+12.4% ▲
5Y CAGR: -3.2%
Shareholders Equity
$457M
-9.7% ▼
5Y CAGR: -9.6%
Cash & Investments
$65M
-24.4% ▼
5Y CAGR: -22.7%
Total Debt
$133M
+4.1% ▲
5Y CAGR: -1.8%
Net Debt
$68M
+62.5% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $334M | $340M | $162M | $86M | $65M |
| Short-Term Investments | $0 | $3M | $0 | $0 | $0 |
| Cash & ST Investments | $334M | $343M | $162M | $86M | $65M |
| Net Receivables | $0 | $143M | $106M | $78M | $77M |
| Inventory | $75M | $48M | $65M | $40M | $45M |
| Other Current Assets | $145M | $22M | $8M | $12M | $12M |
| Total Current Assets | $577M | $558M | $344M | $216M | $198M |
| Property, Plant & Equip. | $457M | $401M | $413M | $386M | $402M |
| Goodwill & Intangibles | $128M | $102M | $97M | $151M | $149M |
| Long-Term Investments | -$13M | -$2M | $9M | $0 | $0 |
| Other Non-Current Assets | $2M | $30M | $55M | $12M | $0 |
| Total Non-Current Assets | $587M | $530M | $573M | $549M | $550M |
| Total Assets | $1.2B | $1.1B | $917M | $765M | $748M |
| — Liabilities — | |||||
| Accounts Payable | $105M | $71M | $118M | $67M | $79M |
| Short-Term Debt | $57M | $65M | $96M | $124M | $87M |
| Deferred Revenue | $0 | $112M | $0 | $0 | $0 |
| Other Current Liabilities | $78M | $208M | $93M | $59M | $72M |
| Total Current Liabilities | $272M | $362M | $313M | $251M | $238M |
| Long-Term Debt | $91M | $62M | $8M | $0 | $42M |
| Other Non-Current Liab. | $948 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $103M | $72M | $12M | $8M | $53M |
| Total Liabilities | $375M | $434M | $325M | $259M | $291M |
| — Equity — | |||||
| Common Stock | $215M | $215M | $215M | $215M | $215M |
| Retained Earnings | $0 | $97M | $71M | $0 | $0 |
| Accumulated OCI | $0 | -$49M | -$59M | $0 | $0 |
| Total Stockholders Equity | $757M | $628M | $592M | $506M | $457M |
| Total Liabilities & Equity | $1.2B | $1.1B | $917M | $765M | $748M |
| — Key Metrics — | |||||
| Total Debt | $160M | $141M | $114M | $127M | $133M |
| Net Debt | -$174M | -$199M | -$49M | $42M | $68M |
| Total Investments | -$13M | $741K | $9M | $0 | $0 |